- Conditions
- Adhesion of Flexor Tendon of Hand
- Interventions
- Collagenase, Collagenase injection
- Drug
- Lead sponsor
- Stony Brook University
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2008
- U.S. locations
- 1
- States / cities
- Stony Brook, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 89
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Dupuytren's Disease
- Interventions
- collagenase clostridium histolyticum
- Biological
- Lead sponsor
- Stony Brook University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 38 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2008
- U.S. locations
- 1
- States / cities
- Stony Brook, New York
- Conditions
- Cellulite, Edematous Fibrosclerotic Panniculopathy (EFP)
- Interventions
- EN3835
- Drug
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 7 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Coral Gables, Florida
- Conditions
- Cellulite
- Interventions
- Collagenase, Biological
- Drug · Biological
- Lead sponsor
- Stony Brook University
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- Stony Brook, New York
- Conditions
- Diabetic Foot Ulcers, Foot Wounds
- Interventions
- Santyl, Control
- Drug · Procedure
- Lead sponsor
- Healthpoint
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 48 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 9
- States / cities
- Phoenix, Arizona • Lincoln, Nebraska • Altoona, Pennsylvania + 6 more
- Conditions
- Adhesive Capsulitis, Frozen Shoulder
- Interventions
- EN3835, Placebo
- Drug
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 198 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 38
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Tucson, Arizona + 33 more
- Conditions
- Edematous Skin
- Interventions
- collagenase clostridium histolyticum (CCH)
- Drug
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 64 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2019
- U.S. locations
- 5
- States / cities
- Coral Gables, Florida • Miami, Florida • New York, New York
- Conditions
- Dupuytren's Disease
- Interventions
- Clostridial collagenase injectable
- Biological
- Lead sponsor
- Indiana Hand to Shoulder Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 37 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2012
- U.S. locations
- 2
- States / cities
- Indianaplis, Indiana • Stony Brook, New York
- Conditions
- Contracture
- Interventions
- Active XIAFLEX Collagenase injection
- Biological
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2031
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Edematous Fibrosclerotic Panniculopathy (EFP), Cellulite
- Interventions
- EN3835
- Drug
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years to 60 Years · Female only
- Enrollment
- 153 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2021
- U.S. locations
- 11
- States / cities
- Encino, California • San Diego, California • Solana Beach, California + 8 more
- Conditions
- Edematous Fibrosclerotic Panniculopathy (EFP)
- Interventions
- Collagenase Clostridium Histolyticum, Placebo
- Biological
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 10
- States / cities
- San Diego, California • Santa Monica, California • Coral Gables, Florida + 7 more
- Conditions
- Dupuytren Contracture
- Interventions
- Radiation therapy
- Radiation
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Other
- Eligibility
- 45 Years and older
- Enrollment
- 95 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2032
- U.S. locations
- 1
- States / cities
- Lebanon, New Hampshire
- Conditions
- Dupuytren's Disease
- Interventions
- Not listed
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 645 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 23
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Burbank, California + 20 more
- Conditions
- Ulcer, Wounds
- Interventions
- Active Leptospermum Honey (Medihoney), Collagenase
- Device · Drug
- Lead sponsor
- Integra LifeSciences Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Edematous Fibrosclerotic Panniculopathy
- Interventions
- CCH (collagenase clostridium histolyticum)
- Biological
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 12 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Dupuytren's Contracture
- Interventions
- collagenase
- Drug
- Lead sponsor
- State University of New York
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1995 – 2004
- U.S. locations
- 2
- States / cities
- Palo Alto, California • Stony Brook, New York
- Conditions
- Lipoma
- Interventions
- AA4500, placebo
- Drug
- Lead sponsor
- Gerut, Zachary, M.D.
- Individual
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 19 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2016
- U.S. locations
- 2
- States / cities
- Hewlett, New York • Nashville, Tennessee
- Conditions
- Plantar Fasciitis
- Interventions
- Collagenase Clostridium Histolyticum (CCH), Placebo
- Biological
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 231 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024
- U.S. locations
- 39
- States / cities
- Tucson, Arizona • Castro Valley, California • Corona, California + 32 more
- Conditions
- Peyronie's Disease
- Interventions
- Xiaflex® 0.58 mg
- Drug
- Lead sponsor
- Manhattan Medical Research Practice, PLLC
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Edematous Fibrosclerotic Panniculopathy
- Interventions
- Previously Treated with EN3835
- Drug
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020
- U.S. locations
- 4
- States / cities
- Clearwater, Florida • Coral Gables, Florida • Washington, Missouri + 1 more
- Conditions
- Diabetic Foot Ulcers (DFUs)
- Interventions
- Bonvadis® (NWBOT), Clostridial Collagenase Ointment
- Device
- Lead sponsor
- Oneness Biotech Co., Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 10
- States / cities
- North Port, Florida • Palm Coast, Florida • South Miami, Florida + 7 more
- Conditions
- Edematous Fibrosclerotic Panniculopathy, Cellulite
- Interventions
- Collagenase Clostridium Histolyticum
- Biological
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 259 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 15
- States / cities
- Beverly Hills, California • Murrieta, California • Oceanside, California + 11 more
- Conditions
- Foot Ulcer, Diabetic Foot
- Interventions
- Collagenase ointment, Modified Contact Cast System
- Drug · Device
- Lead sponsor
- University of Miami
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 4 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Dupuytren's Disease
- Interventions
- XIAFLEX
- Biological
- Lead sponsor
- Hospital for Special Surgery, New York
- Other
- Eligibility
- 35 Years and older
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- New York, New York